Skip to content

Tongue Dysbiosis Effects on Arterial Pressure of Periodontitis Patients

Effects of Tongue Bacterial Dysbiosis Related to Periodontal Therapy on Arterial Pressure Control Based on Salivary Nitrite Availability: a Periodontitis Patients Randomized Controlled Clinical Trial

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04027179
Acronym
TODY
Enrollment
90
Registered
2019-07-19
Start date
2020-08-31
Completion date
2022-07-31
Last updated
2019-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Normal Blood Pressure, Periodontitis

Brief summary

Blood pressure control is crucial for individuals' wellbeing. However, many daily aspects such as diet could impair blood pressure control. In addition, many people living under different conditions in different countries are affected by some kind of gum disease. These people experience gingival bleeding, bad breath, teeth mobility and pain. Throughout gum disease development the number of oral germs in the mouth increases including their levels in tongue surface. Oral bacterial are able to convert nitrate widely found in food in nitrite which influences blood pressure. Frequently treatment of gum diseases general combines manual instrumentation with mouthwashes. However, it has been suggested that reduction of oral bacteria by mouthwashes, especially chlorhexidine, is accompanied by decreased conversion of nitrate to nitrite and that this minor nitrite availability would increase blood pressure. Therefore, this is a point to be clarified for patients, physicians and dentists. This study will investigate the relation between treatment with mouthwashes and blood pressure of patients with destructive gum disease based on nitrite levels in saliva, bacterial levels in tongue and values of arterial blood pressure which will be monitored over 6 months. In addition, usual clinical parameters and alteration of oral cells' DNA will be also monitored overtime. Patients will be treated under local anesthesia and manual instrumentation within 24 hours. They will receive oral care products too. There will be 3 treatment groups (manual instrumentation + chlorhexidine mouthwash \[2 times a day for 3 weeks\], manual instrumentation + placebo mouthwash \[2 times a day for 3 weeks\] and manual instrumentation + no mouthwash) and 2 dental appointments before treatment. After treatment, patients will be examined at 7, 14, 21, 90 and 180 days. Saliva, plaque and cell sampling will be fast and by no invasive methods.

Interventions

DRUG0.12% chlorhexidine digluconate mouthwash

0.12% chlorhexidine digluconate mouthwash (20mL/60 seconds/ 2 times a day/ 3 weeks).

Full-mouth scaling and root planing with manual curettes within 24 hours in two sections 1 hour each.

DRUGPlacebo mouthwash

placebo mouthwash (20mL/60 seconds/ 2 times a day/ 3 weeks).

Sponsors

Conselho Nacional de Desenvolvimento Científico e Tecnológico
CollaboratorOTHER_GOV
University of Taubate
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
35 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* 12 natural teeth; chronic periodontitis stages II and III; no systemic medication; non smokers; normal blood pressure; no mouthwash regular use; antibiotics \> 3 months prior to study; dental treatment \> 3 months prior to study.

Exclusion criteria

\- known alergy to chlorhexidine; removable prosthodontics apparatus; pregnant and breast feeding women.

Design outcomes

Primary

MeasureTime frameDescription
Efficacy - comparative tongue bacterial countsBaseline and 3 monthsChanges of Veillonella, Streptococcus, Neisseria, Fusobacterium and Acytinomyces counts in samples from tongue dorsal

Secondary

MeasureTime frameDescription
Safety - comparative nitrite levels in salivaBaseline and 3 monthsDifferences in mean nitrite levels from saliva samples pre- and post-treatment
Safety - Percentage of hypertension episodesBaseline and 3 monthsChanges in the percentage of hypertension episode
Safety - status of DNA methylation in oral cellsBaseline and 3 monthsMean changes of DNA methylation statuses in oral cells
Efficacy - Percentage of periodontal pocketsBaseline and 6 monthsChanges in the percentage of deep periodontal pockets

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026